Eli Drinkwitz asked permission first. As his time on the SEC’s weekly media teleconference ended, Missouri football’s head coach checked in with the moderator, SEC communications director Chuck Dunlap ...

Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

Former North Carolina coach Mack Brown picked a very curious time to post a congratulatory message for New England Patriots quarterback Drake Maye on Monday morning. After Maye's Patriots took down ...

AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer’s agreement to lower its drug prices for Medicaid and a White House decision ...

Before Glen Powell strapped on a dollar-store wig and a mustache so bushy it needs its own landscaping crew — all for Hulu’s latest comedic experiment, Chad Powers — his titular character belonged to ...

Colts quarterback Daniel Jones has plenty of history with the Mannings. Enough to joke around with Peyton and Eli on ESPN’s “The Manningcast” on Monday night, making his appearance in the second ...

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ...

The Los Angeles Chargers have a future Hall of Famer on their defense in pass rusher Khalil Mack. While he's near the end of his career, Mack hasn't shown signs of slowing down any time soon. The ...

Eli Manning was once considered an enemy in the Lone Star State because of his tough games against the Dallas Cowboys in the 2000s and 2010s. Manning likely still has a few friends in the Metroplex.

IN recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave the world Ozempic, lost a quarter of its market value in a day after it cut ...

Pharmaceutical giant Eli Lilly unveiled plans to build a $6.5 billion biomanufacturing plant in northeast Houston within the next five years, bolstering the region’s bid to become a national ...

Indianapolis-based pharmaceutical giant Eli Lilly confirms plans to build a $5 billion manufacturing facility just west of Richmond, Virginia. (Courtesy Eli Lilly) Indianapolis-based pharmaceutical ...